Mutation of the Parkinsonism Gene ATP13A2 Causes Neuronal Ceroid-lipofuscinosis

Overview

Journal Hum Mol Genet

Specialties Genetics
Molecular Biology

Date 2012 Mar 6

PMID 22388936

Citations 121

Authors

Jose Bras

Alain Verloes

Susanne A Schneider

Sara E Mole

Rita J Guerreiro

Affiliations

Soon will be listed here.

Abstract

Neuronal ceroid lipofuscinoses (NCLs) comprise a heterogeneous group of metabolic storage diseases that present with the accumulation of autofluorescent lipopigment, neurodegeneration and premature death. Nine genes have been thus far identified as the cause of different types of NCL, with ages at onset ranging from around birth to adult, although the underlying etiology of the disease still remains elusive. We present a family with typical NCL pathology in which we performed exome sequencing and identified a single homozygous mutation in ATP13A2 that fully segregates with disease within the family. Mutations in ATP13A2 are a known cause of Kufor-Rakeb syndrome (KRS), a rare parkinsonian phenotype with juvenile onset. These data show that NCL and KRS may share etiological features and implicate the lysosomal pathway in Parkinson's disease.

Citing Articles

Spastic Paraplegia Type 78 Associated With ATP13A2 Gene Variants in Compound Heterozygosity.

Ramirez R, Gasco N, Palmero L, Bueno G, Yamanaka E, Andujar J Mol Genet Genomic Med. 2025; 13(2):e70073.

PMID: 39935284 PMC: 11814479. DOI: 10.1002/mgg3.70073.

Neuronal Ceroid Lipofuscinosis-Concepts, Classification, and Avenues for Therapy.

Zhang Y, Du B, Zou M, Peng B, Rao Y CNS Neurosci Ther. 2025; 31(2):e70261.

PMID: 39925015 PMC: 11808193. DOI: 10.1111/cns.70261.

Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases.

Nixon R, Rubinsztein D Nat Rev Mol Cell Biol. 2024; 25(11):926-946.

PMID: 39107446 DOI: 10.1038/s41580-024-00757-5.

Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities.

Erb M, Sipple K, Levine N, Chen X, Moore D NPJ Parkinsons Dis. 2024; 10(1):133.

PMID: 39030200 PMC: 11271504. DOI: 10.1038/s41531-024-00748-5.

Genetic heterogeneity in epilepsy and comorbidities: insights from Pakistani families.

Yasin M, Licchetta L, Khan N, Ullah I, Jan Z, Dawood M BMC Neurol. 2024; 24(1):172.

PMID: 38783254 PMC: 11112905. DOI: 10.1186/s12883-024-03671-7.

References

Lavrov A, Ilyna E, Zakharova E, Boukina A, Tishkanina S . The first three Russian cases of classical, late-infantile, neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol. 2002; 6(3):161-4. DOI: 10.1053/ejpn.2002.0584. View

Sidransky E, Nalls M, Aasly J, Aharon-Peretz J, Annesi G, Barbosa E . Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009; 361(17):1651-61. PMC: 2856322. DOI: 10.1056/NEJMoa0901281. View

Anderson G, Smith V, Malone M, Sebire N . Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre. J Clin Pathol. 2005; 58(12):1305-10. PMC: 1770783. DOI: 10.1136/jcp.2005.027045. View

Nijssen P, Brusse E, Leyten A, Martin J, Teepen J, Roos R . Autosomal dominant adult neuronal ceroid lipofuscinosis: parkinsonism due to both striatal and nigral dysfunction. Mov Disord. 2002; 17(3):482-7. DOI: 10.1002/mds.10104. View

Hannun Y, Obeid L . Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008; 9(2):139-50. DOI: 10.1038/nrm2329. View

Tome F, Brunet P, Fardeau M, Hentati F, REIX J . Familial disorder of the central and peripheral nervous systems with particular cytoplasmic lamellated inclusions in peripheral nerves, muscle satellite cells, and blood capillaries. Acta Neuropathol. 1985; 68(3):209-17. DOI: 10.1007/BF00690197. View

Crosiers D, Ceulemans B, Meeus B, Nuytemans K, Pals P, Van Broeckhoven C . Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. Parkinsonism Relat Disord. 2010; 17(2):135-8. DOI: 10.1016/j.parkreldis.2010.10.011. View

Ning Y, Kanai K, Tomiyama H, Li Y, Funayama M, Yoshino H . PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology. 2008; 70(16 Pt 2):1491-3. DOI: 10.1212/01.wnl.0000310427.72236.68. View

Di Fonzo A, Chien H, Socal M, Giraudo S, Tassorelli C, Iliceto G . ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology. 2007; 68(19):1557-62. DOI: 10.1212/01.wnl.0000260963.08711.08. View

10.

Burneo J, Arnold T, Palmer C, Kuzniecky R, Oh S, Faught E . Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama. Epilepsia. 2003; 44(6):841-6. DOI: 10.1046/j.1528-1157.2003.39802.x. View

11.

Wohlke A, Philipp U, Bock P, Beineke A, Lichtner P, Meitinger T . A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier. PLoS Genet. 2011; 7(10):e1002304. PMC: 3192819. DOI: 10.1371/journal.pgen.1002304. View

12.

CARLIER G, Dubru J . Familial juvenile Parkinsonism. Acta Paediatr Belg. 1979; 32(2):123-7. View

13.

Lei X, Zhang S, Bohrer A, Bao S, Song H, Ramanadham S . The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Biochemistry. 2007; 46(35):10170-85. PMC: 2530898. DOI: 10.1021/bi700017z. View

14.

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

15.

Vilarino-Guell C, Soto A, Lincoln S, Ben Yahmed S, Kefi M, Heckman M . ATP13A2 variability in Parkinson disease. Hum Mutat. 2008; 30(3):406-10. PMC: 2650009. DOI: 10.1002/humu.20877. View

16.

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

17.

Taschner P, De Vos N, Thompson A, Callen D, Doggett N, Mole S . Chromosome 16 microdeletion in a patient with juvenile neuronal ceroid lipofuscinosis (Batten disease). Am J Hum Genet. 1995; 56(3):663-8. PMC: 1801154. View

18.

Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P . Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain. 2009; 2:5. PMC: 2644690. DOI: 10.1186/1756-6606-2-5. View

19.

Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid L . Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006; 38(10):1184-91. DOI: 10.1038/ng1884. View

20.

De Volder A, Cirelli S, de Barsy T, BRUCHER J, Bol A, Michel C . Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET. J Neurol Neurosurg Psychiatry. 1990; 53(12):1063-7. PMC: 488316. DOI: 10.1136/jnnp.53.12.1063. View